The FDA issued a public health notification regarding use of surgical mesh for the repair of pelvic organ prolapsed and stress urinary incontinence. Surgical mesh has caused severe complications in some patients.
The FDA has issued a public health notification regarding use of surgical mesh for the repair of pelvic organ prolapsed and stress urinary incontinence. Surgical mesh has caused severe complications in some patients. While a lawsuit is pending, surgical mesh is still being used. The FDA recommends physicians obtain specialized training and be aware of the potential risks, thoroughly inform patients of adverse risks, and monitor patients closely for complications.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More